Craig M. Wilson

发表

Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing

Peter L. Anderson, Samantha MaWhinney, David V. Glidden, 2016, Antimicrobial Agents and Chemotherapy.

Prevalence and Risk Factors for HPV in HIV-Positive Young Women Receiving Their First HPV Vaccination

K. Squires, R. Burk, Jiahong Xu, 2012, Journal of acquired immune deficiency syndromes.

Host genetics and HIV-1 viral load set-point in African–Americans

R. Kaslow, S. Shrestha, Wei-Zheng Song, 2009, AIDS.

Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults.

S. Douglas, C. Stephensen, Craig M. Wilson, 2007, The American journal of clinical nutrition.

Epidemiology of HIV Infection and Risk in Adolescents and Youth

J. Safrit, P. Wright, Craig M. Wilson, 2010, Journal of acquired immune deficiency syndromes.

Rates and Correlates of Antiretroviral Therapy Use and Virologic Suppression Among Perinatally and Behaviorally HIV-Infected Youth Linked to Care in the United States

J. Bauermeister, Craig M. Wilson, P. Wilson, 2015, Journal of acquired immune deficiency syndromes.

Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025

S. Vermund, G. Gray, J. McIntyre, 2004, Journal of acquired immune deficiency syndromes.

Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein

K. Mulligan, C. Stephensen, B. Rutledge, 2013, Front. Genet..

Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth

S. Shrestha, Wei-Zheng Song, B. Kapogiannis, 2009, Human Genetics.

US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function.

A. Carriquiry, C. Stephensen, Craig M. Wilson, 2004, Journal of the American Dietetic Association.

Racial disparities and factors associated with prescription for smoking cessation medications among smokers receiving routine clinical care for HIV

A. Westfall, J. Willig, K. Cropsey, 2020, AIDS care.

Mitochondrial DNA diversity in the African American population

S. Shrestha, R. Makowsky, Craig M. Wilson, 2015, Mitochondrial DNA.

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, The Journal of clinical endocrinology and metabolism.

Prevalence of Proteinuria and Elevated Serum Cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) Study

P. Muntner, R. Christenson, S. Shrestha, 2012, Journal of acquired immune deficiency syndromes.

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

C. Gordon, M. Van Loan, K. Mulligan, 2013, Antimicrobial Agents and Chemotherapy.

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.

M. Van Loan, K. Mulligan, C. Stephensen, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV

S. Nichols, C. Kahler, A. Westfall, 2017, Sexually Transmitted Infections.

The relationships between substance abuse, psychosocial variables, and natural killer cell enumeration and function in HIV-infected and high-risk uninfected adolescents.

Jiahong Xu, S. Douglas, D. Murphy, 2003, AIDS research and human retroviruses.

HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination

R. Kaslow, Wei-Zheng Song, Craig M. Wilson, 2004, Hepatology.

Vitamins D Status in adolescents and young adults with HIV infection

G. Aldrovandi, S. Douglas, C. Stephensen, 2006, American Journal of Clinical Nutrition.

The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents

S. Shrestha, Jennifer S. Smith, L. Bachmann, 2010, BMC infectious diseases.

T-Lymphocyte Subsets in HIV-Infected and High-Risk HIV-Uninfected Adolescents: Retention of Naive T Lymphocytes in HIV-Infected Adolescents

S. Vermund, S. Douglas, D. Campbell, 2000 .

Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project.

S. Vermund, G. Mcgwin, H. Ding, 2009, Archives of pediatrics & adolescent medicine.

HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes.

C. Stephensen, Craig M. Wilson, G. Marquis, 2004, Journal of the American Dietetic Association.

Assessment of Thymic Activity in Human Immunodeficiency Virus-Negative and -Positive Adolescents by Real-Time PCR Quantitation of T-Cell Receptor Rearrangement Excision Circles

J. Church, S. Douglas, P. Krogstad, 2003, Clinical Diagnostic Laboratory Immunology.

High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus

J. Palefsky, E. Stier, S. Lensing, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incident Anal Human Papillomavirus and Human Papillomavirus–Related Sequelae in HIV-Infected Versus HIV-Uninfected Adolescents in the United States

Craig M. Wilson, J. Kahn, B. Rudy, 2013, Sexually transmitted diseases.

Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men☆☆☆

J. Palefsky, E. Stier, Xiaofei Chi, 2019, Papillomavirus research.

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa

S. Delany-Moretlwe, L. Bekker, S. Hosek, 2016, Journal of the International AIDS Society.

Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.

S. Self, L. Bekker, H. Jaspan, 2008, Journal of acquired immune deficiency syndromes.

Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort.

J. Lindsey, R. Bosch, S. Douglas, 2006, AIDS research and human retroviruses.

Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a Southeastern US clinic.

S. Vermund, J. Willig, I. Aban, 2011, Journal of public health dentistry.

Sexually transmitted infections among HIV infected and HIV uninfected high-risk youth in the REACH study. Reaching for Excellence in Adolescent Care and Health.

S. Vermund, A. Moscicki, Craig M. Wilson, 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens

B. Kapogiannis, Craig M. Wilson, B. Rudy, 2011, Journal of acquired immune deficiency syndromes.

Identification of three immunologic correlates for HIV type 1 pathogenesis in youth.

Wei-Zheng Song, Craig M. Wilson, Jianming Tang, 2011, AIDS research and human retroviruses.

Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents

S. Vermund, A. Moscicki, S. Douglas, 1999 .

Vitamin D status in adolescents and young adults with HIV infection 1-3

G. Aldrovandi, S. Douglas, C. Stephensen, 2006 .

Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.

C. Gordon, K. Mulligan, S. Hosek, 2019, AIDS research and human retroviruses.

Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone

C. Gordon, K. Mulligan, C. Stephensen, 2018, Antiviral therapy.

Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial

Miguel Ángel Martínez, D. Harris, C. Gordon, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

KIR2DS4 Promotes HIV-1 Pathogenesis: New Evidence from Analyses of Immunogenetic Data and Natural Killer Cell Function

G. Alter, P. Goepfert, R. Kaslow, 2014, PloS one.

CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.

R. Kaslow, S. Douglas, Craig M. Wilson, 2002, AIDS research and human retroviruses.

CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population.

A. Moscicki, J. Ellenberg, S. Douglas, 2004, AIDS research and human retroviruses.

Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans

L. Gardner, J. Sobel, R. Kaslow, 2009, Journal of Virology.

TH1 and TH2 Cytokine mRNA and Protein Levels in Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Youths

A. Moscicki, K. Sullivan, S. Douglas, 2003, Clinical Diagnostic Laboratory Immunology.

Youths ( HIV )-Seropositive and HIV-Seronegative Levels in Human Immunodeficiency Virus TH 1 and TH 2 Cytokine mRNA and Protein

A. Moscicki, K. Sullivan, S. Douglas, 2003 .

HIV Voluntary Counseling and Testing among Injection Drug Users in South China: A Study of a Non-Government Organization Based Program

S. Vermund, J. Schumacher, Craig M. Wilson, 2007, AIDS and Behavior.

Cost-effectiveness of frequent HIV screening among high-risk young men who have sex with men in the United States.

M. Weinstein, R. Walensky, S. Resch, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Delayed Onset of Pubertal Development in Children and Adolescents With Perinatally Acquired HIV Infection

M. Hughes, J. Lindsey, K. Buchacz, 2003, Journal of acquired immune deficiency syndromes.

Sexual Risk Behavior Among Virologically Detectable Human Immunodeficiency Virus-Infected Young Men Who Have Sex With Men.

G. Harper, K. Mayer, Craig M. Wilson, 2016, JAMA pediatrics.

The Acceptability and Feasibility of an HIV Preexposure Prophylaxis (PrEP) Trial With Young Men Who Have Sex With Men

S. Hosek, G. Siberry, B. Rutledge, 2013, Journal of acquired immune deficiency syndromes.

Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis

C. Gordon, M. Van Loan, K. Mulligan, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.

D. Harris, G. Aldrovandi, R. Fielding, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana

E. Funkhouser, S. Person, F. Shuaib, 2010, Tropical medicine & international health : TM & IH.

Randomized Trial to Determine Safety and Immunogenicity of Two Strategies for Hepatitis B Vaccination in Healthy Urban Adolescents in the United States

Jiahong Xu, B. Kapogiannis, Craig M. Wilson, 2010, The Pediatric infectious disease journal.

Incidence, Prevalence, and Epidemiology of Herpes Simplex Virus-2 in HIV-1-Positive and HIV-1-Negative Adolescents

S. Shrestha, E. Hook, Craig M. Wilson, 2012, Sexually transmitted diseases.

Transmission Risk Among Youth Living With HIV in the U.S.

J. Fortenberry, A. Westfall, S. Hosek, 2020, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Vitamin D3 Supplementation Increases Fibroblast Growth Factor-23 in HIV-Infected Youths Treated with Tenofovir Disoproxil Fumarate

C. Gordon, M. Van Loan, K. Mulligan, 2014, Antiviral therapy.

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

D. Harris, K. Mayer, G. Zimet, 2017, JAMA pediatrics.

CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.

S. Douglas, Craig M. Wilson, S. Pahwa, 2003, AIDS research and human retroviruses.

Comprehension of a simplified assent form in a vaccine trial for adolescents

D. Hoffman, B. Kapogiannis, Craig M. Wilson, 2013, Journal of Medical Ethics.

Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents.

R. Kaslow, W. Geisler, Craig M. Wilson, 2004, The Journal of infectious diseases.

Tobacco Use and Sustained Viral Suppression in Youth Living with HIV

A. Westfall, S. Hosek, K. Gamarel, 2018, AIDS and Behavior.

Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.

K. Squires, Jiahong Xu, B. Kapogiannis, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association between anemia and aflatoxin B1 biomarker levels among pregnant women in Kumasi, Ghana.

E. Funkhouser, S. Person, F. Shuaib, 2010, The American journal of tropical medicine and hygiene.

Oral Lesions: PoorMarkers of Virologic Failure in HIV-Infected Patients on Antiretroviral Therapy

S. Vermund, I. Aban, I. Tamí-Maury, 2015 .

Oral Lesions: Poor Markers of Virologic Failure in HIV-Infected Patients on Antiretroviral Therapy

S. Vermund, J. Willig, I. Aban, 2013 .

Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States

L. Benet, P. Bacchetti, S. Hosek, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

THE ASSOCIATION BETWEEN AFLATOXIN B1 BIOMARKER LEVELS IN PREGNANT WOMEN AND BIRTH OUTCOMES IN KUMASI, GHANA

E. Funkhouser, S. Person, W. Ellis, 2010 .

Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents

A. Moscicki, D. Murphy, Craig M. Wilson, 2003, AIDS.

Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir-Ritonavir in Adolescents and Young Adults with Human Immunodeficiency Virus Infection

D. Harris, C. Fletcher, B. Kapogiannis, 2007, Antimicrobial Agents and Chemotherapy.

Enzymes of pyrimidine salvage pathways in intraerythrocytic Plasmodium falciparum.

Craig M. Wilson, F. Naguib, M. H. el Kouni, 2018, The international journal of biochemistry & cell biology.

Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.

D. Murphy, M. Belzer, Craig M. Wilson, 2005, Archives of pediatrics & adolescent medicine.

Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.

S. Spector, L. Peralta, G. Aldrovandi, 2006, The Journal of infectious diseases.

Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.

D. Szydlo, K. Squires, K. Bunge, 2020, Journal of acquired immune deficiency syndromes.

Barriers to HAART adherence among human immunodeficiency virus-infected adolescents.

A. Moscicki, D. Murphy, Craig M. Wilson, 2003, Archives of pediatrics & adolescent medicine.

Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.

S. Perumean-Chaney, K. Mulligan, S. Hosek, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Interleukin-10 Gene (IL10) Polymorphisms and Human Papillomavirus Clearance among Immunosuppressed Adolescents

R. Kaslow, S. Shrestha, Craig M. Wilson, 2007, Cancer Epidemiology Biomarkers & Prevention.

Barriers to HIV testing-where next?

S. Vermund, Craig M. Wilson, 2002, The Lancet.

Seroprevalence and Risk Factors of Hepatitis B, Hepatitis C, and Human Cytomegalovirus Among HIV‐Infected and High‐Risk Uninfected Adolescents: Findings of the REACH Study

A. Moscicki, L. Levin, Craig M. Wilson, 2000, Sexually Transmitted Diseases.

Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents

J. Kappes, K. Yusim, P. Goepfert, 2007, AIDS.

Cytokine and Chemokine Gene Polymorphisms Among Ethnically Diverse North Americans With HIV-1 Infection

R. Kaslow, Wei-Zheng Song, S. Douglas, 2004, Journal of acquired immune deficiency syndromes.

Short Communication: Relationship of CD4+ T Cell Counts and HIV Type 1 Viral Loads in Untreated, Infected Adolescents

L. Kingsley, A. Moscicki, J. Ellenberg, 2000 .

Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents

B. Korber, S. Vermund, M. Mulligan, 2002, AIDS.

HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1

D. Cornforth, I. Williams, P. Borrow, 2006, The Journal of Immunology.

Variants Efficiently Disease Progression Cross-Recognize Epitope Responses Strongly Associated with Delayed T Cell + HIV-1 Epitope-Specific CD 8

D. Cornforth, I. Williams, P. Borrow, 2006 .

CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides

M. Mulligan, G. Aldrovandi, K. Yusim, 2005, AIDS.

Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.

B. Korber, M. Mulligan, P. Goepfert, 2003, Journal of acquired immune deficiency syndromes.

Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients

P. Goepfert, J. Mulenga, S. Allen, 2006, AIDS.

The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.

L. Gardner, J. Sobel, R. Kaslow, 2011, Human immunology.

Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.

B. Chi, J. Stringer, M. Sinkala, 2007, JAMA.

Peripheral Blood Lymphocyte Subsets in Adolescents: a Longitudinal Analysis from the REACH Project

A. Moscicki, S. Douglas, Craig M. Wilson, 2002, Clinical and Vaccine Immunology.

Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.

D. Harris, S. Stoszek, G. Aldrovandi, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans

R. Kaslow, S. Shrestha, Craig M. Wilson, 2014, AIDS.

Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents.

R. Kaslow, W. Geisler, Craig M. Wilson, 2005, The Journal of infectious diseases.

T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles.

Bette Korber, Anju Bansal, James Tang, 2003, AIDS research and human retroviruses.

Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges

S. Delany-Moretlwe, S. McCormack, T. Hallett, 2016 .

Immunogenetic Correlates of Neisseria gonorrhoeae Infection in Adolescents

R. Kaslow, W. Geisler, Craig M. Wilson, 2008, Sexually transmitted diseases.

Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061

K. Squires, J. Sleasman, B. Kapogiannis, 2015, Journal of acquired immune deficiency syndromes.

Interleukin-10 (IL-10) Pathway: Genetic Variants and Outcomes of HIV-1 Infection in African American Adolescents

R. Kaslow, S. Shrestha, Wei-Zheng Song, 2010, PloS one.

Performance of Antigens Used in Detecting Delayed-Type Hypersensitivity in Adolescents Infected with the Human Immunodeficiency Virus

J. Ellenberg, L. Peralta, S. Douglas, 2001, Clinical Diagnostic Laboratory Immunology.

An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM

K. Mayer, G. Zimet, K. Mulligan, 2017, Journal of acquired immune deficiency syndromes.

Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.

S. Perumean-Chaney, S. Hosek, A. Patki, 2019, Journal of acquired immune deficiency syndromes.

The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.

S. Perumean-Chaney, S. Hosek, A. Patki, 2018, Journal of acquired immune deficiency syndromes.

Linking HIV-Negative Youth to Prevention Services in 12 U.S. Cities: Barriers and Facilitators to Implementing the HIV Prevention Continuum.

Denise L. Roseland, J. Fortenberry, C. Boyer, 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Vitamins C and E in adolescents and young adults with HIV infection.

R. Jacob, S. Douglas, C. Stephensen, 2006, The American journal of clinical nutrition.

Immune Activation and Oxidative Damage in HIV-Positive and HIV-Negative Adolescents

S. Douglas, C. Stephensen, Craig M. Wilson, 2005, Journal of acquired immune deficiency syndromes.

A measure to assess HIV treatment readiness among adolescents and young adults

A. Westfall, S. Hosek, M. I. Fernandez, 2019, Vulnerable children and youth studies.

HIV Continuum of Care for Youth in the United States

J. Fortenberry, A. Westfall, Jiahong Xu, 2017, Journal of acquired immune deficiency syndromes.

Partner Notification for Youth Living With HIV in 14 Cities in the United States

A. Westfall, M. Javanbakht, P. Gorbach, 2017, Journal of acquired immune deficiency syndromes.

Title : Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent 1 Dosing 2 3 Running title : FTC-TP in DBS to quantify recent dosing 4 5

D. Glidden, R. Grant, E. Gardner, 2016 .

Mental health disorders and alcohol use are associated with increased likelihood of smoking relapse among people living with HIV attending routine clinical care

A. Westfall, J. Willig, K. Cropsey, 2019, BMC Public Health.

Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV

S. Woods, S. Nichols, P. Garvie, 2015, Journal of NeuroVirology.

Prevalence, Incidence, and Recurrence of Oral Lesions Among HIV-Infected Patients on HAART in Alabama: A Two-Year Longitudinal Study

S. Vermund, J. Willig, I. Aban, 2011, Southern medical journal.

Predictors of smoking cessation among people living with HIV receiving routine clinical care

A. Westfall, J. Willig, K. Cropsey, 2019, AIDS care.

Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.

S. Shrestha, Craig M. Wilson, Jianming Tang, 2012, Journal of reproductive immunology.

Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care

A. Westfall, J. Willig, K. Cropsey, 2015, Journal of AIDS & clinical research.

Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.

E. Kabagambe, J. Sleasman, B. Kapogiannis, 2013, AIDS research and human retroviruses.

Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression

J. Goedert, J. Margolick, M. Prins, 2006, AIDS.

Transitional Probability-Based Model for HPV Clearance in HIV-1-Positive Adolescent Females

I. Akushevich, E. Levitan, S. Shrestha, 2012, PloS one.

Evaluating Testing Strategies for Identifying Youths With HIV Infection and Linking Youths to Biomedical and Other Prevention Services

J. Fortenberry, C. Boyer, R. Miller, 2017, JAMA pediatrics.

Implementation of an Integrated Approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths

J. Fortenberry, J. Ellen, L. Koenig, 2017, JAMA pediatrics.

Calibration and validation of an oral fluid‐based sensitive/less‐sensitive assay to distinguish recent from established HIV‐1 infections

L. Peralta, Craig M. Wilson, N. Constantine, 2007, Journal of clinical laboratory analysis.

Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.

L. Peralta, Craig M. Wilson, N. Constantine, 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.

J. Sleasman, B. Kapogiannis, Craig M. Wilson, 2012, AIDS patient care and STDs.

Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.

S. Shrestha, Craig M. Wilson, H. Wiener, 2013, Human immunology.

Prior incarceration associated with missed HIV care visits among young people living with HIV in the US

J. Fortenberry, Craig M. Wilson, J. J. van den Berg, 2020, AIDS care.

Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.

J. Sleasman, B. Kapogiannis, Craig M. Wilson, 2009, AIDS research and human retroviruses.

Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.

S. Douglas, D. Campbell, Craig M. Wilson, 2002, AIDS research and human retroviruses.

Hormonal contraceptive use and response to antiretroviral therapy among adolescent females

S. Shrestha, Craig M. Wilson, M. Kempf, 2011 .

Interleukin (IL)‐2 and IL‐12 responses to Chlamydia trachomatis infection in adolescents

R. Kaslow, W. Geisler, Craig M. Wilson, 2005, Clinical and experimental immunology.

Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA

Craig M. Wilson, J. Kahn, B. Rudy, 2013, International journal of STD & AIDS.

Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.

C. Wilson, D. Wirth, D. Kyle, 1993, Molecular and biochemical parasitology.

Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network.

L. Kingsley, A. Moscicki, J. Ellenberg, 2000, AIDS research and human retroviruses.

Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.

C. Wilson, J. Le bras, A. Mazabraud, 1995, Molecular and biochemical parasitology.

Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA

D. Murphy, M. Belzer, Craig M. Wilson, 2001, AIDS care.

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

J. Ellenberg, L. Peralta, M. Belzer, 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men